Clinical Trial

Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2024 (before its estimated August 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study, a single-center, open, single-dose clinical study, was designed to evaluate the safety and efficacy of IM96 CAR-T cells in treating patients with advanced colorectal cancer
Trial Details
NCT Number NCT06718738
Lead Sponsor Beijing Immunochina Medical Science & Technology Co., Ltd.
Collaborators: Peking University Cancer Hospital & Institute
Conditions Colorectal Cancer (CRC)
Enrollment 9 participants
Start Date 2024-12-15
Primary Completion 2025-08-15 (estimated)
Study Completion 2026-08-15 (estimated)
Updated on ClinicalTrials.gov 2024-12-05